Geographic variation in <scp>HCV</scp> treatment penetration among people who inject drugs in Baltimore, <scp>MD</scp>
Catelyn Coyle(Merck & Co., Inc., Rahway, NJ, USA (United States)), Becky L. Genberg(Johns Hopkins University), Oluwaseun Falade‐Nwulia(Johns Hopkins University), David L. Thomas(Johns Hopkins University), Shruti H. Mehta(Johns Hopkins University), Jacquie Astemborski(New York Academy of Medicine), Frank C. Curriero(Johns Hopkins University), Jacqueline E. Rudolph(Johns Hopkins University), Gregory D. Kirk(Uganda Cancer Institute), Michael R. Desjardins(Johns Hopkins University)
Cited by 2
Related Papers
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡
|Hepatology|2006|4.8k
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
|Hepatology|2008|3k
Diagnosis, management, and treatment of hepatitis C†
|Hepatology|2004|1.7k